Legend Biotech Corp ADR (LEGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -53,100 | -282,600 | -263,001 | -223,928 | -99,200 |
| Depreciation Amortization | 15,600 | 28,900 | 16,932 | 11,053 | 5,100 |
| Accounts receivable | 11,400 | -5,700 | 5,510 | -20,280 | 5,900 |
| Accounts payable and accrued liabilities | -8,100 | 44,400 | 60,302 | 36,035 | 19,500 |
| Other Working Capital | -75,300 | -93,100 | -61,975 | -109,181 | -74,000 |
| Other Operating Activity | 24,400 | 207,900 | 154,237 | 189,505 | 39,100 |
| Operating Cash Flow | $-85,100 | $-100,200 | $-87,995 | $-116,796 | $-103,600 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 4,655,064 | N/A | N/A |
| PPE Investments | -7,500 | -28,600 | -16,231 | -11,226 | -2,000 |
| Purchase Of Investment | N/A | -5,000 | N/A | N/A | N/A |
| Other Investing Activity | -160,500 | 743,200 | -4,567,719 | 102,341 | 258,600 |
| Investing Cash Flow | $-168,000 | $709,600 | $71,114 | $91,115 | $256,600 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 100 | 3,300 | 2,989 | 1,717 | 1,400 |
| Other Financing Activity | -1,300 | -3,600 | -2,642 | -2,040 | -800 |
| Financing Cash Flow | $-1,200 | $-300 | $347 | $-323 | $600 |
| Exchange Rate Effect | -1,200 | 6,100 | 8,678 | 5,841 | 1,400 |
| Beginning Cash Position | 901,900 | 286,700 | 286,749 | 286,749 | 286,700 |
| End Cash Position | 646,400 | 901,900 | 278,893 | 266,586 | 441,700 |
| Net Cash Flow | $-255,500 | $615,200 | $-7,856 | $-20,163 | $155,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -85,100 | -100,200 | -87,995 | -116,796 | -103,600 |
| Capital Expenditure | -7,500 | -28,600 | -16,231 | -11,226 | -2,000 |
| Free Cash Flow | -92,600 | -128,800 | -104,226 | -128,022 | -105,600 |